摘要： 在 mRNA 新冠疫苗实现大规模量产的辉煌之后，Moderna、BioNTech 等行业巨头正转向更具挑战性的个性化癌症疗法领域。这类量身定制的疗法虽与新冠疫苗原理相通，却面临样本处理、生产协调、时效把控等多重难题。企业纷纷借力 AI 优化流程、缩短周期，同时在临床定位与监管审批上稳步推进，全力攻克这一精准医疗的关键关卡。从量产到定制：全新挑战降临 ...

Moderna (MRNA), with its widely used COVID-19 vaccine, rose to prominence during the global pandemic. The stock soared an eye ...

Investing.com - Needham在 Moderna (NASDAQ:MRNA) 周五在ESMO会议上展示新癌症疗法数据后维持其"持有"评级，该公司目前交易价格为$26.01，市值为101.6亿美元。根据 InvestingPro ...

摘要： 在2025年欧洲肿瘤内科学会（ESMO）大会上，抗体偶联药物（ADC）成为绝对焦点。各大药企密集披露合作与临床数据，新一代疗法展现技术突破，但行业内也存在不同声音，ADC 领域的 “过山车” 行情持续上演。巨头加码，交易与数据双爆发 ...

CAMBRIDGE, MA / ACCESS Newswire / October 19, 2025 / Moderna, Inc. (NASDAQ:MRNA) today announced data regarding two of its ...

智通财经APP获悉，周三， Moderna (MRNA.US) 股价走高，截至发稿，该股涨超6.7%，报29.17美元。消息面上，美国疾病控制与预防中心 ...

Over the last year, Noubar Afeyan has watched Cambridge-based Moderna go from perhaps the world’s most celebrated company ...

Discover whether Moderna or BioNTech offers better long-term investment potential as both pivot from COVID-19 to innovative ...

Moderna has shared some of the phase 1/2 data that persuaded it to expand and p | Moderna has shared some of the phase 1/2 ...

Then, demand for its COVID-19 vaccine started to diminish. As hospitals resumed normal operations and anti-vaccine sentiment ...

Noubar Afeyan tells the STAT Summit that political moves to replace facts with opinions won't stop with mRNA vaccines. "It’s ...

2025年10月6日， Moderna（MRNA）披露1笔公司内部人交易情况。高管Mock James M于2025年10月3日卖出703股。 Moderna, ...